Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥79.81 Million ≈ $11.68 Million USD) by net assets (CN¥3.72 Billion ≈ $543.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shandong Jincheng Pharmaceutical and Che liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Jincheng Pharmaceutical and Chemical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hangzhou Haoyue Personal Care Co Ltd
SHG:605009
|
0.031x |
|
Transcat Inc
NASDAQ:TRNS
|
0.041x |
|
INMODE LTD IS -01
F:154
|
0.023x |
|
Infund Holding Co Ltd
SHE:002141
|
0.075x |
|
Gerresheimer AG
F:GXI
|
0.042x |
|
Vina Concha To
SN:CONCHATORO
|
-0.031x |
|
Huayi Brothers Media Corp
SHE:300027
|
0.016x |
|
Alok Industries Limited
NSE:ALOKINDS
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Shandong Jincheng Pharmaceutical and Che.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.72 Billion ≈ $544.93 Million |
CN¥319.64 Million ≈ $46.77 Million |
0.086x | +10.90% |
| 2024-12-31 | CN¥3.83 Billion ≈ $560.76 Million |
CN¥296.59 Million ≈ $43.40 Million |
0.077x | -55.93% |
| 2023-12-31 | CN¥3.78 Billion ≈ $553.29 Million |
CN¥664.08 Million ≈ $97.18 Million |
0.176x | +151.42% |
| 2022-12-31 | CN¥3.66 Billion ≈ $535.47 Million |
CN¥255.63 Million ≈ $37.41 Million |
0.070x | -45.04% |
| 2021-12-31 | CN¥3.44 Billion ≈ $503.30 Million |
CN¥437.19 Million ≈ $63.97 Million |
0.127x | -19.30% |
| 2020-12-31 | CN¥3.47 Billion ≈ $507.37 Million |
CN¥546.13 Million ≈ $79.92 Million |
0.158x | +11.32% |
| 2019-12-31 | CN¥4.08 Billion ≈ $597.74 Million |
CN¥577.98 Million ≈ $84.58 Million |
0.141x | +64.24% |
| 2018-12-31 | CN¥4.09 Billion ≈ $598.21 Million |
CN¥352.20 Million ≈ $51.54 Million |
0.086x | +123.44% |
| 2017-12-31 | CN¥3.94 Billion ≈ $576.20 Million |
CN¥151.83 Million ≈ $22.22 Million |
0.039x | -75.98% |
| 2016-12-31 | CN¥1.50 Billion ≈ $220.11 Million |
CN¥241.48 Million ≈ $35.34 Million |
0.161x | +1.17% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.74 Million |
CN¥207.92 Million ≈ $30.42 Million |
0.159x | -19.26% |
| 2014-12-31 | CN¥1.12 Billion ≈ $163.40 Million |
CN¥219.46 Million ≈ $32.11 Million |
0.197x | +113.78% |
| 2013-12-31 | CN¥1.02 Billion ≈ $149.51 Million |
CN¥93.92 Million ≈ $13.74 Million |
0.092x | +3.55% |
| 2012-12-31 | CN¥975.57 Million ≈ $142.76 Million |
CN¥86.61 Million ≈ $12.67 Million |
0.089x | +35.78% |
| 2011-12-31 | CN¥958.84 Million ≈ $140.31 Million |
CN¥62.69 Million ≈ $9.17 Million |
0.065x | -77.42% |
| 2010-12-31 | CN¥375.33 Million ≈ $54.92 Million |
CN¥108.67 Million ≈ $15.90 Million |
0.290x | -22.83% |
| 2009-12-31 | CN¥281.53 Million ≈ $41.20 Million |
CN¥105.62 Million ≈ $15.46 Million |
0.375x | +168.69% |
| 2008-12-31 | CN¥216.49 Million ≈ $31.68 Million |
CN¥30.23 Million ≈ $4.42 Million |
0.140x | -- |
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.